Loading…
Fierce Biotech Next Gen 2022 has ended
Back To Schedule
Wednesday, June 29 • 10:50am - 11:10am
Executive Interview: Jason Martin, Vice President, Cell Therapy Operations Global Manufacturing Science and Technology, Bristol Myers Squibb

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Moderators
avatar for Fraiser Kansteiner

Fraiser Kansteiner

Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →

Speakers
avatar for Jason Martin

Jason Martin

Vice President, Cell Therapy Operations Global Manufacturing Science & Technology, Bristol Myers Squibb
Jason has over 25 years of biopharmaceutical experience at industry leading companies BMS, Celgene, Novartis, and Merck & Co. Inc.  He is currently the Vice President, Cell Therapy Operations, Global Manufacturing Science & Technology at BMS where he leads a global team supporting... Read More →

Wednesday June 29, 2022 10:50am - 11:10am EDT
  Executive Interview